Lancet retracts covid-19 HCQ study flagging risks on data integrity concerns

WHO has said clinical trials of repurposed anti-malaria drug hydroxychloroquine for treatment of covid-19 will resume, after a committee reviewed the available data for the drug

from Livemint - Science https://ift.tt/379QtPe
https://ift.tt/eA8V8J